The anti-tumor actions of individual cellular components of the immune system have been extensively documented and used as a base for new cancer treatments, including the class of drugs known as anti-programmed cell death protein 1 (PD-1) inhibitors [11, 12]. The gene discussed is PDCD1; the disease is neoplasm.